For research use only. Not for therapeutic Use.
GlyT2-IN-1(CAT: I003585) is a compound that acts as an inhibitor of glycine transporter 2 (GLYT2). GlyT2 is responsible for the reuptake of glycine from the synapse, playing a crucial role in regulating glycine levels and synaptic transmission. By inhibiting GLYT2, GlyT2-IN-1 can increase glycine concentrations in the synaptic cleft, leading to enhanced glycine neurotransmission. This compound has been studied for its potential therapeutic applications in neurological and psychiatric disorders, such as schizophrenia and neuropathic pain, where modulating glycine transmission may have beneficial effects.
Catalog Number | I003585 |
CAS Number | 448947-81-7 |
Synonyms | 2-[5-[[(2,6-dichlorophenyl)methyl]thio]-1,3,4-thiadiazol-2-yl]-pyrazine |
Molecular Formula | C13H8Cl2N4S2 |
Purity | ≥95% |
Target | GLYT2 |
Solubility | DMSO: ≥ 34 mg/mL |
Storage | 4°C |
InChIKey | BQNXBSYSQXSXPT-UHFFFAOYSA-N |
Reference | <p style=/line-height:25px/> |